Triple-negative breast cancer accounts for approximately 10 to 20 percent of all breast cancer cases. It is more likely to affect younger women, African American women, and women with BRCA1 mutations. Treatment options may include chemotherapy, surgery, and radiation therapy. Clinical trials are also exploring new treatments and therapies for TNBC.... Read More